CD163 and neoplasm: In GD, GlcCer accumulation due to lysosomal β-glucocerebrosidase deficiency results in the persistent expression of tumor-associated macrophage markers (e.g., CD163), CD206-positive bone marrow mesenchymal stromal cells, and activated CD4+T cells.